Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence. 2020

Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
Division of Colorectal Surgery, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan.

Ampullary adenocarcinoma is a rare gastrointestinal cancer in which WNT signalling dysregulation has been previously reported. Secreted frizzled related protein 1 (SFRP1) is one of the extracellular ligands of WNT signalling. We performed bioinformatics analyses of SFRP1 expression in human cancer. Microarray analysis of SFRP1 in periampullary adenocarcinoma was obtained from the Gene Expression Omnibus GSE39409 dataset. SFRP1 expression in ampullary adenocarcinoma was detected by immunohistochemistry staining and correlated with patients' clinical outcomes. Our results showed that SFRP1 expression had different clinical applications in all types of human cancer. No detected alteration of SFPR1 gene and SFRP1 expression in ampullary adenocarcinoma was lower than that in other periampullary adenocarcinomas. However, high expression levels of SFRP1 protein were correlated with cancer recurrence, peritoneal carcinomatosis and poor patient prognosis. Gene set enrichment analysis showed downregulation of multiple WNT-related genes in primary culture cells from ampullary adenocarcinoma, but SFRP1 expression was increased. We found an interaction between WNT, bone morphogenetic protein and hedgehog signalling with SFRP1. Furthermore, a high expression of SFRP1 predicted poor prognosis for ampullary adenocarcinoma patients. Because it is a multifunctional protein, SFRP1 targeting serves as a potential therapy for ampullary adenocarcinoma patients.

UI MeSH Term Description Entries
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
April 2006, Journal of dental research,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
March 2006, Cancer biology & therapy,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
January 2004, The Journal of biological chemistry,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
October 2012, European journal of immunology,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
February 2018, Journal of Asian natural products research,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
April 2018, Current eye research,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
August 2010, The American journal of pathology,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
June 2008, Journal of molecular histology,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
January 2009, Journal of the American Society of Nephrology : JASN,
Li-Chin Cheng, and Ying- Jui Chao, and Michael J Overman, and Chih -Yang Wang, and Nam Nhut Phan, and Yi-Ling Chen, and Tzu-Wen Wang, and Hui-Ping Hsu, and Yan-Shen Shan, and Ming- Derg Lai
August 2006, Cancer,
Copied contents to your clipboard!